Hutch News
Results per Page:
Translocation tracker: digital droplet PCR in chronic myelogenous leukemia
From the Radich Lab, Clinical Research Division
Leukemia researcher Dr. Jerry Radich receives Kurt Enslein Endowed Chair
New chair continues legacy of giving sparked by lifesaving care
Fred Hutch global health research honored for impact, collaboration
Washington Global Health Alliance awardees include Dr. Benjamin O. Anderson and a collaboration between Dr. Jerald Radich and The Max Foundation
‘Let the cells tell the story’
New tech is giving scientists unprecedented insights into single cells’ inner workings
Taking the shortcut to frontline treatment
From Dr. Schmitt and the Radich lab, Clinical Research Division
Rolling up the miles for cancer research
Obliteride riders, walkers top $2 million in Fred Hutch fundraiser
Deciphering tumor diversity at the single cell level
from the Radich lab, Clinical Research Division
$7 million grants boost functional genomics team science
Dr. Chris Kemp’s 2 NCI awards will help support drug-target discovery and commercialization for personalized oncology
Jake Diekman stars at Hutch Award luncheon
Texas Rangers pitcher becomes 53rd recipient of coveted baseball honor
Good News: iCMLf honors Dr. Jerald Radich, and more
Celebrating faculty and staff achievements
Key stories of Fred Hutch research from 2016
A roundup of some of our favorite 2016 stories on research at Fred Hutch
A little card with a big task: Saving lives from CML
Researchers develop low-cost, paper-based diagnostic for use in low-income countries
Bike ride to raise cancer funds is personal for 3 'Obliteriders'
For Nancy Evans, Brian Tracy and Dr. Jerry Radich, this weekend’s fundraising bike ride is personal
Good News at Fred Hutch
Celebrating faculty and staff achievements
Beginner’s guide to Obliteride
Practical tips and motivating takeaways to help you rock your ride
Consortium presents genomic symposium May 23
Discuss effects of genomics on cancer therapy at this free symposium; registration required
Clocking cancer progression
Collaborative study with Rosetta charts molecular timeline of chronic myeloid leukemia progression, holds promise for improving patient care